Literature DB >> 31754030

Systematic phenomics analysis of autism-associated genes reveals parallel networks underlying reversible impairments in habituation.

Troy A McDiarmid1, Manuel Belmadani2,3, Joseph Liang1, Fabian Meili1, Eleanor A Mathews4, Gregory P Mullen5, Ardalan Hendi6, Wan-Rong Wong7, James B Rand4,8, Kota Mizumoto6, Kurt Haas1, Paul Pavlidis1,2,3, Catharine H Rankin9,10.   

Abstract

A major challenge facing the genetics of autism spectrum disorders (ASDs) is the large and growing number of candidate risk genes and gene variants of unknown functional significance. Here, we used Caenorhabditis elegans to systematically functionally characterize ASD-associated genes in vivo. Using our custom machine vision system, we quantified 26 phenotypes spanning morphology, locomotion, tactile sensitivity, and habituation learning in 135 strains each carrying a mutation in an ortholog of an ASD-associated gene. We identified hundreds of genotype-phenotype relationships ranging from severe developmental delays and uncoordinated movement to subtle deficits in sensory and learning behaviors. We clustered genes by similarity in phenomic profiles and used epistasis analysis to discover parallel networks centered on CHD8•chd-7 and NLGN3•nlg-1 that underlie mechanosensory hyperresponsivity and impaired habituation learning. We then leveraged our data for in vivo functional assays to gauge missense variant effect. Expression of wild-type NLG-1 in nlg-1 mutant C. elegans rescued their sensory and learning impairments. Testing the rescuing ability of conserved ASD-associated neuroligin variants revealed varied partial loss of function despite proper subcellular localization. Finally, we used CRISPR-Cas9 auxin-inducible degradation to determine that phenotypic abnormalities caused by developmental loss of NLG-1 can be reversed by adult expression. This work charts the phenotypic landscape of ASD-associated genes, offers in vivo variant functional assays, and potential therapeutic targets for ASD.

Entities:  

Keywords:  Caenorhabditis elegans; autism spectrum disorder; habituation learning; neurodevelopmental disorders; variants of uncertain significance

Mesh:

Substances:

Year:  2019        PMID: 31754030      PMCID: PMC6968627          DOI: 10.1073/pnas.1912049116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  83 in total

1.  Systematic analysis of genes required for synapse structure and function.

Authors:  Derek Sieburth; QueeLim Ch'ng; Michael Dybbs; Masoud Tavazoie; Scott Kennedy; Duo Wang; Denis Dupuy; Jean-François Rual; David E Hill; Marc Vidal; Gary Ruvkun; Joshua M Kaplan
Journal:  Nature       Date:  2005-07-28       Impact factor: 49.962

2.  Autism-associated missense genetic variants impact locomotion and neurodevelopment in Caenorhabditis elegans.

Authors:  Wan-Rong Wong; Katherine I Brugman; Shayda Maher; Jun Young Oh; Kevin Howe; Mihoko Kato; Paul W Sternberg
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

3.  Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments.

Authors:  J Liang; W Xu; Y-T Hsu; A X Yee; L Chen; T C Südhof
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

4.  A high-resolution C. elegans essential gene network based on phenotypic profiling of a complex tissue.

Authors:  Rebecca A Green; Huey-Ling Kao; Anjon Audhya; Swathi Arur; Jonathan R Mayers; Heidi N Fridolfsson; Monty Schulman; Siegfried Schloissnig; Sherry Niessen; Kimberley Laband; Shaohe Wang; Daniel A Starr; Anthony A Hyman; Tim Schedl; Arshad Desai; Fabio Piano; Kristin C Gunsalus; Karen Oegema
Journal:  Cell       Date:  2011-04-29       Impact factor: 41.582

5.  Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene.

Authors:  D Levitan; I Greenwald
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

6.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.

Authors:  Brian J O'Roak; Laura Vives; Santhosh Girirajan; Emre Karakoc; Niklas Krumm; Bradley P Coe; Roie Levy; Arthur Ko; Choli Lee; Joshua D Smith; Emily H Turner; Ian B Stanaway; Benjamin Vernot; Maika Malig; Carl Baker; Beau Reilly; Joshua M Akey; Elhanan Borenstein; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Jay Shendure; Evan E Eichler
Journal:  Nature       Date:  2012-04-04       Impact factor: 49.962

7.  Pathogenic mechanism of an autism-associated neuroligin mutation involves altered AMPA-receptor trafficking.

Authors:  S Chanda; J Aoto; S-J Lee; M Wernig; T C Südhof
Journal:  Mol Psychiatry       Date:  2015-03-17       Impact factor: 15.992

8.  Functional significance of rare neuroligin 1 variants found in autism.

Authors:  Moe Nakanishi; Jun Nomura; Xiao Ji; Kota Tamada; Takashi Arai; Eiki Takahashi; Maja Bućan; Toru Takumi
Journal:  PLoS Genet       Date:  2017-08-25       Impact factor: 5.917

9.  Neurexin controls plasticity of a mature, sexually dimorphic neuron.

Authors:  Michael P Hart; Oliver Hobert
Journal:  Nature       Date:  2018-01-10       Impact factor: 49.962

Review 10.  Intellectual disability and autism spectrum disorders 'on the fly': insights from Drosophila.

Authors:  Mireia Coll-Tané; Alina Krebbers; Anna Castells-Nobau; Christiane Zweier; Annette Schenck
Journal:  Dis Model Mech       Date:  2019-05-13       Impact factor: 5.758

View more
  16 in total

1.  Midbrain circuits of novelty processing.

Authors:  Andrew R Tapper; Susanna Molas
Journal:  Neurobiol Learn Mem       Date:  2020-10-11       Impact factor: 2.877

2.  Functional testing of ASD-associated genes.

Authors:  Marla B Sokolowski
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-10       Impact factor: 11.205

3.  cacna2d3, a voltage-gated calcium channel subunit, functions in vertebrate habituation learning and the startle sensitivity threshold.

Authors:  Nicholas J Santistevan; Jessica C Nelson; Elelbin A Ortiz; Andrew H Miller; Dima Kenj Halabi; Zoë A Sippl; Michael Granato; Yevgenya Grinblat
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

Review 4.  Synaptic dysfunction connects autism spectrum disorder and sleep disturbances: A perspective from studies in model organisms.

Authors:  Fusun Doldur-Balli; Toshihiro Imamura; Olivia J Veatch; Naihua N Gong; Diane C Lim; Michael P Hart; Ted Abel; Matthew S Kayser; Edward S Brodkin; Allan I Pack
Journal:  Sleep Med Rev       Date:  2022-01-25       Impact factor: 11.401

5.  Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.

Authors:  Sarah E M Stephenson; Gregory Costain; Laura E R Blok; Michael A Silk; Thanh Binh Nguyen; Xiaomin Dong; Dana E Alhuzaimi; James J Dowling; Susan Walker; Kimberly Amburgey; Robin Z Hayeems; Lance H Rodan; Marc A Schwartz; Jonathan Picker; Sally A Lynch; Aditi Gupta; Kristen J Rasmussen; Lisa A Schimmenti; Eric W Klee; Zhiyv Niu; Katherine E Agre; Ilana Chilton; Wendy K Chung; Anya Revah-Politi; P Y Billie Au; Christopher Griffith; Melissa Racobaldo; Annick Raas-Rothschild; Bruria Ben Zeev; Ortal Barel; Sebastien Moutton; Fanny Morice-Picard; Virginie Carmignac; Jenny Cornaton; Nathalie Marle; Orrin Devinsky; Chandler Stimach; Stephanie Burns Wechsler; Bryan E Hainline; Katie Sapp; Marjolaine Willems; Ange-Line Bruel; Kerith-Rae Dias; Carey-Anne Evans; Tony Roscioli; Rani Sachdev; Suzanna E L Temple; Ying Zhu; Joshua J Baker; Ingrid E Scheffer; Fiona J Gardiner; Amy L Schneider; Alison M Muir; Heather C Mefford; Amy Crunk; Elizabeth M Heise; Francisca Millan; Kristin G Monaghan; Richard Person; Lindsay Rhodes; Sarah Richards; Ingrid M Wentzensen; Benjamin Cogné; Bertrand Isidor; Mathilde Nizon; Marie Vincent; Thomas Besnard; Amelie Piton; Carlo Marcelis; Kohji Kato; Norihisa Koyama; Tomoo Ogi; Elaine Suk-Ying Goh; Christopher Richmond; David J Amor; Jessica O Boyce; Angela T Morgan; Michael S Hildebrand; Antony Kaspi; Melanie Bahlo; Rún Friðriksdóttir; Hildigunnur Katrínardóttir; Patrick Sulem; Kári Stefánsson; Hans Tómas Björnsson; Simone Mandelstam; Manuela Morleo; Milena Mariani; Marcello Scala; Andrea Accogli; Annalaura Torella; Valeria Capra; Mathew Wallis; Sandra Jansen; Quinten Weisfisz; Hugoline de Haan; Simon Sadedin; Sze Chern Lim; Susan M White; David B Ascher; Annette Schenck; Paul J Lockhart; John Christodoulou; Tiong Yang Tan
Journal:  Am J Hum Genet       Date:  2022-04-07       Impact factor: 11.043

6.  Neuroligin dependence of social behaviour in Caenorhabditis elegans provides a model to investigate an autism-associated gene.

Authors:  Helena Rawsthorne; Fernando Calahorro; Emily Feist; Lindy Holden-Dye; Vincent O'Connor; James Dillon
Journal:  Hum Mol Genet       Date:  2021-01-06       Impact factor: 6.150

7.  Systematic phenomics analysis of autism-associated genes reveals parallel networks underlying reversible impairments in habituation.

Authors:  Troy A McDiarmid; Manuel Belmadani; Joseph Liang; Fabian Meili; Eleanor A Mathews; Gregory P Mullen; Ardalan Hendi; Wan-Rong Wong; James B Rand; Kota Mizumoto; Kurt Haas; Paul Pavlidis; Catharine H Rankin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-21       Impact factor: 11.205

Review 8.  Chromatin Remodeler CHD8 in Autism and Brain Development.

Authors:  Anke Hoffmann; Dietmar Spengler
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

9.  Brain-wide visual habituation networks in wild type and fmr1 zebrafish.

Authors:  Emmanuel Marquez-Legorreta; Lena Constantin; Marielle Piber; Itia A Favre-Bulle; Michael A Taylor; Ann S Blevins; Jean Giacomotto; Dani S Bassett; Gilles C Vanwalleghem; Ethan K Scott
Journal:  Nat Commun       Date:  2022-02-16       Impact factor: 17.694

10.  Confounds of using the unc-58 selection marker highlights the importance of genotyping co-CRISPR genes.

Authors:  Helena Rawsthorne-Manning; Fernando Calahorro; Patricia G Izquierdo; Philippe Tardy; Thomas Boulin; Lindy Holden-Dye; Vincent O'Connor; James Dillon
Journal:  PLoS One       Date:  2022-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.